+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
From
Histone Deacetylase 6 - Pipeline Insight, 2024 - Product Thumbnail Image

Histone Deacetylase 6 - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
CDK9 inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

CDK9 inhibitor - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Non-melanoma Skin Cancer Market 2024-2028 - Product Thumbnail Image

Non-melanoma Skin Cancer Market 2024-2028

  • Report
  • July 2024
  • 145 Pages
  • Global
From
From
Type 2 Diabetes Treatment: Global Market Outlook - Product Thumbnail Image

Type 2 Diabetes Treatment: Global Market Outlook

  • Report
  • December 2022
  • 66 Pages
  • Global
From
From
From
From
Bronchitis Treatment Market Report 2025 - Product Thumbnail Image

Bronchitis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Cervical Intraepithelial Neoplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Cervical Intraepithelial Neoplasia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
Loading Indicator